Connect with us

Technology

Surgical Robots Market to Grow by USD 14.02 Billion (2024-2028), Rising Adoption for Convenience Drives Growth, Report on AI-Driven Market Transformation – Technavio

Published

on

NEW YORK, Nov. 26, 2024 /PRNewswire/ — Report with the AI impact on market trends – The global surgical robots market size is estimated to grow by USD 14.02 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 27.17% during the forecast period. High adoption due to convenience is driving market growth, with a trend towards high demand from developing countries. However, cost and affordability associated with surgical robots poses a challenge.Key market players include Accuray Inc., Asensus Surgical US Inc., CMR Surgical Ltd., Intuitive Surgical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Microbot Medical Inc., Momentis Innovative Surgery Ltd., Neocis Inc., Novus International Inc., OMNI Orthopaedics Inc., Renishaw Plc, Siemens AG, Smith and Nephew plc, Stryker Corp., Titan Medical Inc, United Orthopedic Corp., Virtual Incision, and Zimmer Biomet Holdings Inc..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Surgical Robots Market Scope

Report Coverage

Details

Base year

2023

Historic period

2018 – 2022

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 27.17%

Market growth 2024-2028

USD 14021.3 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

20.98

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key countries

US, UK, Germany, China, and Japan

Key companies profiled

Accuray Inc., Asensus Surgical US Inc., CMR Surgical Ltd., Intuitive Surgical Inc., Johnson and Johnson Services Inc., Medtronic Plc, Microbot Medical Inc., Momentis Innovative Surgery Ltd., Neocis Inc., Novus International Inc., OMNI Orthopaedics Inc., Renishaw Plc, Siemens AG, Smith and Nephew plc, Stryker Corp., Titan Medical Inc, United Orthopedic Corp., Virtual Incision, and Zimmer Biomet Holdings Inc.

Market Driver

Surgical robots are revolutionizing the healthcare industry with their precision and minimally invasive capabilities. The market for surgical robots is growing, particularly in the outpatient and ambulatory surgery segments. HD cameras and automated instruments are key trends in this market, enabling surgeons to perform complex procedures with greater accuracy. The urological surgery segment is a major contributor, with a high demand for robotic assistance in procedures like prostatectomies and nephrectomies. General surgery, gynaecological surgery, neurosurgery, and oncology segments also show strong growth. Surgical robots are increasingly being used in ambulatory surgery centers and clinics, reducing the need for inpatient facilities. Medicare coverage and the rising number of surgical errors have fueled the adoption of these systems. Orthopedic surgeries for bone degenerative diseases like arthritis, osteoporosis, hip replacement surgeries, and knee replacement surgeries are common applications. Minimally invasive techniques are preferred due to faster recovery times and smaller scars. Surgical robotic systems are being used for a wide range of procedures, from cardiac surgery and cataract surgery to neurosurgeries and cancer treatment procedures. The market for instruments and accessories is also growing. The future of surgical robots lies in miniaturization and the ability to perform complex procedures with greater precision. Healthcare providers are investing in these systems to improve patient outcomes and reduce costs. 

Surgical robotics technology is experiencing significant growth in demand, particularly in developing countries. Healthcare systems in these regions aim to improve patient outcomes and enhance healthcare services. Developing countries, such as India and Brazil, often face a shortage of specialized surgeons. Surgical robots offer a solution by providing a platform for training and skill development. These systems include simulation capabilities, enabling surgeons to practice complex procedures in a controlled environment, thereby improving their proficiency and delivering better patient care. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

Surgical robots have revolutionized the healthcare industry, particularly in areas like urological, general, and gynaecological surgeries. However, challenges persist. HD cameras and miniaturization are key advancements, but costs remain high. Outpatient surgery and ambulatory surgery centers are growing, but Medicare reimbursement policies need clarification. Surgical errors are a concern, especially in complex procedures like neurosurgeries and oncology. The U.S. Market for surgical robots is expanding, driven by orthopedic surgeries for bone degenerative diseases like arthritis and osteoporosis. Replacement rates for hip and knee surgeries are increasing, with primary hip replacement and primary knee replacement being common procedures. Physicians and surgeons are adopting automated instruments for minimally invasive surgeries, benefiting adults with chronic diseases like cancer. Instruments and accessories for soft tissues and bones are in demand, as are surgical robotic systems for laparoscopy and general surgical procedures. The outpatient segment, including ambulatory surgical centers and surgical centers, is growing, shifting focus from inpatient facilities. Traditional surgery techniques face competition from minimally invasive ones, with brain surgeries and neurological disorders being key areas of development. Surgical intervention for cardiac surgery, cataract surgery, hernia repair, cholecystectomy, adrenalectomy, small bowel resection, and rectal prolapse are all potential applications. The future of surgical robots lies in continuous innovation and collaboration between healthcare providers and technology companies.Surgical robots have become a notable trend in healthcare, offering enhanced capabilities for surgical procedures. However, the financial aspect of acquiring and maintaining these robotic systems is a substantial challenge in the market. The initial investment for purchasing and installing surgical robots, as well as ongoing expenses for staff training, maintenance, and instrument sterilization, can be substantial. Regular maintenance is crucial for optimal performance and longevity, involving inspections, software updates, and equipment calibration, which may result in additional costs, such as service contracts or technician fees.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This surgical robots market report extensively covers market segmentation by

Application 1.1 General and laparoscopy surgery1.2 Gynecological surgery1.3 Orthopedic surgery1.4 Neurosurgery1.5 Urology and othersEnd-user 2.1 Hospitals2.2 Ambulatory service centersGeography 3.1 North America3.2 Europe3.3 Asia3.4 Rest of World (ROW)

1.1 General and laparoscopy surgery- Surgical robots have significantly increased in popularity for both general and laparoscopic surgeries due to their numerous advantages. According to the World Health Organization, approximately 200-400 million surgical procedures are performed globally each year. These robots offer surgeons enhanced precision and visualization, enabling them to perform complex procedures with minimal scarring, shorter hospital stays, and quicker recovery times. Equipped with advanced instruments like articulated robotic arms and high-definition cameras, surgical robots provide surgeons with a magnified 3D view of the surgery site and improved instrument maneuverability. Furthermore, integration with technologies like augmented reality offers surgeons a more detailed understanding of patient-specific anatomical details. The adoption of surgical robots is projected to boost the growth of the general and laparoscopic surgery market during the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Surgical robots are advanced medical devices that enable HD cameras and automated instruments to perform precise and minimally invasive surgeries. These robots are increasingly being used in outpatient surgery and ambulatory surgery centers for various procedures, including orthopedic surgeries for bone degenerative diseases like arthritis, osteoporosis, hip replacement, and knee replacement surgeries for joints affected by osteoarthritis. Chronic diseases such as cardiac conditions, cancer, and cataracts are also treated with surgical intervention using surgical robots. The use of surgical robots reduces surgical errors, enhances precision, and improves patient outcomes. Medicare and other healthcare providers are recognizing the benefits of these technologies, leading to increased adoption. Instruments and accessories for soft tissues and bones are also available for these robots to expand their capabilities.

Market Research Overview

Surgical robots are advanced medical devices that enable doctors to perform complex surgeries with greater precision and control. These robots, equipped with HD cameras and automated instruments, are increasingly being used in outpatient and ambulatory surgery settings, including ambulatory surgery centers and clinics. Medicare and other healthcare providers are recognizing the benefits of surgical robots, such as reduced surgical errors, shorter hospital stays, and faster recovery times. The urological surgery segment is a significant market for surgical robots, with applications including prostatectomies, nephrectomies, and cystectomies. General surgery, gynaecological surgery, neurosurgery, and oncology are other major application areas. Surgical robots are used in various types of surgeries, including orthopedic surgeries for bone degenerative diseases like arthritis and osteoporosis, hip replacement surgeries, and knee replacement surgeries. Surgical robots are also used in minimally invasive procedures for soft tissues and abnormal structures, such as hernia repair, cholecystectomy, adrenalectomy, and small bowel resection. The market for surgical robots is expected to grow significantly due to the increasing rate of primary hip replacement and primary knee replacement surgeries, as well as the growing number of chronic diseases affecting adults, such as cardiac conditions and cancer. The miniaturization of surgical robotic systems is also driving growth in the market, as these systems can be used in outpatient segment surgical centers and healthcare facilities, reducing the need for inpatient facilities. Traditional surgery techniques are being replaced by minimally invasive techniques, such as laparoscopy, which offer less scarring and faster recovery times. The neurology segment, including neurosurgeries for neurological disorders, is also a growing market for surgical robots. The use of surgical robots in cancer treatment procedures, such as brain surgeries, is expected to drive significant growth in the market. Instruments and accessories are also a significant part of the surgical robots market.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationGeneral And Laparoscopy SurgeryGynecological SurgeryOrthopedic SurgeryNeurosurgeryUrology And OthersEnd-userHospitalsAmbulatory Service CentersGeographyNorth AmericaEuropeAsiaRest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/surgical-robots-market-to-grow-by-usd-14-02-billion-2024-2028-rising-adoption-for-convenience-drives-growth-report-on-ai-driven-market-transformation—technavio-302315625.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

AiRISTA Launches Newest Version of Sofia™, Setting a Standard for Enterprise-Grade Real-Time Location Systems

Published

on

By

Platform modernization delivers unmatched flexibility, enterprise security, and open interoperability — reinforcing AiRISTA’s position as the RTLS platform built to scale with any technology environment

TIMONIUM, Md., July 21, 2026 /PRNewswire/ — AiRISTA, a leading provider of real-time location systems (RTLS) trusted by more than 300 organizations worldwide, today announced the newest release of its flagship Sofia™ real-time location intelligence platform. Building on the foundation established with the Vision RTLS platform, Sofia represents the next evolution of AiRISTA’s location intelligence platform to meet the evolving needs of enterprise and government customers.

As organizations increasingly rely on location intelligence to improve staff safety, operational efficiency, and workflow automation, Sofia enables them to leverage existing technology investments through an open, technology-agnostic platform rather than a single-vendor ecosystem.

Sy Sajjad, Founder and CEO, AiRISTA: “Sofia reflects what we’ve believed since founding AiRISTA: location intelligence should adapt to how an organization actually operates, not force the organization to adapt to a single vendor’s technology. With this release, we’ve strengthened the security, flexibility, and scalability that enterprise and healthcare customers require — while staying true to the open, technology-agnostic architecture that has always set Sofia apart.”

Key enhancements in the new release include:

A modernized user experience with simplified administration

Enterprise-grade security with Single Sign-On (SSO), Multi-Factor Authentication (MFA), TLS 1.3, and enhanced access controls

A centralized Integrations Hub supporting leading wireless infrastructure and enterprise applications, including EHR, MES, nurse call, and other operational systems

Multi-tenant tag roaming for seamless multi-site deployments

Enhanced dashboards, reporting, alert management, and platform performance

Unlike RTLS platforms built around a single positioning technology, Sofia supports Wi-Fi, Bluetooth® Low Energy (BLE), Ultra-Wideband (UWB), infrared (IR), GPS, and RFID within a single platform, allowing organizations to select the right technology for each use case without vendor lock-in. 

Jon Collins, Director of Integrated Product Solutions, AiRISTA: “The latest release of Sofia was built around a simple principle: the platform should improve outcomes, not add complexity. Whether that’s enabling a faster staff duress response, integrating location intelligence with electronic health records (EHRs), manufacturing execution systems (MES), nurse call, or other enterprise applications, or scaling seamlessly across multiple sites, this release removes friction at every layer—for administrators, IT teams, and the frontline staff who rely on Sofia every day. “

Organizations shouldn’t have to replace existing systems to unlock the value of location intelligence. Sofia was designed to integrate with the technologies customers already rely on. The latest release extends that flexibility with a new, centralized Integrations Hub supporting HPE Networking solutions (including HPE Aruba Networking and Juniper Mist), Cisco Spaces, Cisco Meraki, Cisco CMX, and other leading infrastructure platform.

Wyatt Meek, Chief Commercial Officer, AiRISTA: “What we hear consistently from customers evaluating RTLS is that they don’t want to choose between capability and flexibility — they want both. Sofia gives organizations enterprise-grade security and a modernized experience without asking them to give up the freedom to choose the right technology for each use case. That combination is difficult to find elsewhere in this market.”

Sofia is available now. Existing customers can work with their AiRISTA account team to plan upgrades. To learn more, visit www.airistaflow.com.

About AiRISTA

AiRISTA is a leading provider of real-time location systems (RTLS) and location intelligence solutions for healthcare, industrial, and government organizations. Trusted by more than 300 organizations worldwide, the Sofia platform delivers real-time visibility into people, assets, and environments while integrating with a broad ecosystem of wireless infrastructure and enterprise systems. AiRISTA is ISO 9001 and ISO 27001 certified.

View original content to download multimedia:https://www.prnewswire.com/news-releases/airista-launches-newest-version-of-sofia-setting-a-standard-for-enterprise-grade-real-time-location-systems-302830751.html

SOURCE AiRISTA Flow

Continue Reading

Technology

GCG Advisory Partners Reports Strong First-Half 2026, Marked by Four Strategic Acquisitions, $1.1 Billion in New Assets, and Completion of Three-Platform Model

Published

on

By

Firm expands AUM, welcomes new advisory teams, and deepens its national footprint following 2025 recapitalization

CHARLOTTE, N.C., July 21, 2026 /PRNewswire/ — GCG Advisory Partners (“GCG”), a national wealth management aggregator platform, today announced a series of milestones completed in the first half of 2026 that reinforce the firm’s growth trajectory and its position as a partner of choice for independent financial advisors.

Since its August 2025 recapitalization with BharCap Partners, GCG has grown EBITDA by more than 200%, a pace that reflects both a disciplined deal strategy and the caliber of the teams choosing to join. The firm acquires and supports registered investment advisory (RIA) practices nationwide, giving each the infrastructure, capital, and flexibility to keep growing while staying focused on clients.

Completion of the Three-Platform Model

GCG also completed the build-out of its three-platform operating model (independent RIA, broker-dealer/corporate RIA, and hybrid RIA), so advisors can choose the affiliation that best fits their practice and clients. Every prospective partner now has a clear route in, whatever structure they prefer.

Four Acquisitions, Four New Chapters

Gunderson Capital Management. Closed April 3, 2026, this deal added roughly $578 million in AUM, custodied at Charles Schwab, and established GCG’s independent RIA channel. The Mount Pleasant, S.C. firm is led by nationally recognized market commentator Bill Gunderson.

Gateway Capital Advisors. Also effective that day, this $300 million-plus practice joined through an asset purchase, recognized for its entrepreneurial, organically driven growth and deep client-planning work.

Head Investment Partners. In June, this $180 million Knoxville practice joined GCG, led by 30-year advisor Daniel Head and known for its options and risk-management expertise, giving GCG its first footprint in Tennessee.

BlueChip Financial Advisors. A hybrid RIA custodying through Fidelity Institutional Wealth Services, it opened GCG’s first presence in the Northeast and rounded out the firm’s affiliation options, giving incoming teams the full range of ways to join.

Each brings specialized capabilities to GCG’s expanding roster of practices.

Leadership Perspective

“The first half of 2026 has been about disciplined execution: completing our platform, welcoming exceptional advisory teams, and building a firm that advisors and institutional partners alike can trust. We’re proud of what our team has accomplished, and we remain focused on sustainable, high-quality growth, driven by both organic momentum and disciplined acquisitions, through the back half of the year and into 2027.”

— Joel Burris, CEO & Managing Partner, GCG Advisory Partners

Looking Ahead

GCG continues to evaluate new opportunities and remains committed to supporting advisors and clients across all three affiliation models. The firm expects to share further updates later in 2026.

For entrepreneurial advisors looking to build lasting equity in their practice, GCG offers the capital, infrastructure, and partnership to make it happen. To start a confidential conversation, contact our team.

About GCG Advisory Partners

GCG Advisory Partners is a national wealth management aggregator that acquires and supports registered investment advisory practices nationwide. Through its independent RIA, broker-dealer/corporate RIA, and hybrid RIA channels, the firm gives advisors the infrastructure, resources, and flexibility to grow while staying focused on their clients. GCG is backed by BharCap Partners. For more information, visit www.gcgap.com.

Media Contact:

Nicole Caputo
Contact@gcgap.com
704-372-4491

View original content to download multimedia:https://www.prnewswire.com/news-releases/gcg-advisory-partners-reports-strong-first-half-2026–marked-by-four-strategic-acquisitions-1-1-billion-in-new-assets-and-completion-of-three-platform-model-302830173.html

SOURCE GCG Advisory Partners

Continue Reading

Technology

Buzz Health and VetHubRx Partner to Bring Real-Time Prescription Savings to Veterinary Care

Published

on

By

Strategic integration embeds multi-card discount pricing directly into veterinary e-prescribing workflows, expanding affordability and price transparency for pet owners at the pharmacy counter

FORT WALTON BEACH, Fla., July 21, 2026 /PRNewswire/ — Buzz Health™, a healthcare technology company, and VetHubRx, a veterinary e-prescribing platform, today announced a strategic partnership to integrate real-time prescription discount pricing directly into VetHubRx’s e-prescribing and consumer-facing platforms.

Through the collaboration, VetHubRx will embed Buzz Health’s RxCompare® pricing infrastructure into its prescribing workflow, enabling veterinary providers and pet owners to access and apply the lowest available discount price at the point of prescribing and fulfillment. The integration supports automated best-price routing via Buzz Health’s SmartBIN® across a configurable multi-card discount network, delivering real-time price visibility within the digital prescribing experience and seamless claims adjudication through RxCompare’s pharmacy network and infrastructure.

The partnership marks Buzz Health’s first integration with a veterinary e-prescribing platform, extending the company’s prescription affordability technology into a market where most medication purchases are paid entirely out of pocket, given that only 4 to 5% of pets in the U.S. are insured, according to the North American Pet Health Insurance Association.

Unlike human healthcare, pet insurance rarely covers prescription drugs at the point of sale, leaving pet owners fully exposed to retail pricing with limited visibility into available savings. Many pet owners are unaware that the same prescription discount programs available for human medications can also be applied to their pet’s prescriptions, a gap this partnership addresses by embedding savings directly into the prescribing workflow.

“Veterinary prescribing is undergoing a digital transformation, and this partnership positions Buzz Health at the forefront of that shift,” said Lathe Bigler, Senior Vice President, Business Strategy at Buzz Health. “By embedding real-time pricing and multi-card savings directly into the prescribing workflow, we are helping veterinary providers deliver price transparency to pet owners before they arrive at the pharmacy, reducing surprises at the counter and improving prescription fulfillment rates.”

VetHubRx is a standalone e-prescribing application designed for veterinary clinics and animal hospitals, enabling providers to generate and transmit prescriptions electronically to retail pharmacies nationwide. Animal hospitals typically do not dispense medications on-site, meaning prescriptions are mostly routed to retail pharmacies, making real-time pricing visibility at the pharmacy counter particularly valuable. The platform also includes a consumer-facing app that engages pet owners on refills and prescription management.

“Our providers want to give pet owners every advantage when it comes to affording the medications their animals need,” said MJ Hamilton, CEO and Founder of VetHubRx. “Integrating real-time discount pricing into our workflow means pet owners can see the most affordable option at the pharmacy closest to them, all within the same digital experience their veterinarian uses to prescribe. It removes friction from the process and helps ensure prescriptions are filled.”

The partnership focuses on prescriptions for human-equivalent medications commonly prescribed for pets, which are filled at retail pharmacies across the country. The integration applies SmartBIN technology to automatically route each prescription to the discount card offering the lowest available price using a single set of processing codes, ensuring pet owners receive optimal savings with no additional steps required by the prescriber or pharmacist.

Buzz Health currently supports prescription access across thousands of pharmacies nationwide and continues expanding its platform to serve e-prescribing applications, EMR/EHR integrations, and additional enterprise partners.

About Buzz Health

Buzz Health is a healthcare technology company delivering intelligent, customizable prescription solutions through its integrated platforms, including BuzzRx, RxCompare, and RxAffect. Designed for scale and flexibility, Buzz Health’s technology helps streamline pharmacy operations, optimize claims in real time, and improve access and affordability across the prescription ecosystem. By serving as the intelligence layer behind prescription savings and benefit navigation, Buzz Health enables measurable cost reductions, improved adherence, and better health outcomes. Learn more at www.buzzhealth.com.

About VetHubRx

VetHubRx is the first and only e-prescribing platform built exclusively for veterinarians, empowering clinics to electronically prescribe to virtually any participating pharmacy nationwide. By eliminating phone calls, faxes, and unnecessary administrative work, VetHubRx streamlines the prescribing process for veterinary teams while giving pet owners the freedom to fill prescriptions at the pharmacy that best meets their needs. Faster prescribing, greater convenience, and improved access to medications help create a better experience for both clinics and pet owners. Learn more at vethubrx.com.

Media Contact
buzzhealthPR@supremecomms.ai

View original content to download multimedia:https://www.prnewswire.com/news-releases/buzz-health-and-vethubrx-partner-to-bring-real-time-prescription-savings-to-veterinary-care-302828773.html

SOURCE Buzz Health

Continue Reading

Trending